Source link : https://www.newshealth.biz/health-news/tirzepatide-shortage-resolved-fda-says-yes-compounders-no/
On October 2, the US Food and Drug Administration (FDA)’s Drug Shortage Database showed that the tirzepatide injection (Zepbound, Mounjaro/Lilly) shortage is now “resolved.” The agency wrote in a clarification aimed at compounders that Lilly said it can meet the “present and projected national demand” and that compounders are restricted from making the products. Nevertheless, […]
Author : News Health
Publish date : 2024-10-07 07:36:34
Copyright for syndicated content belongs to the linked Source.
inHealth